The MRSA hospital infections

International Review of Allergology and Clinical Immunology

Volumn 14, Issue 3-4, 2008, Pages 101-109

  Bigos, Monika ^a   Denys, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Community acquired infections; Hospital acquired infections; MRSA

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTOBIPROLE; COTRIMOXAZOLE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINCOSAMIDE DERIVATIVE; LINEZOLID; MACROLIDE; METICILLIN; MIKAMYCIN B; ORITAVANCIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; TELAVANCIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIOSTASIS; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE SURVEILLANCE; DRUG EFFICACY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LAW; MALPRACTICE; MEDICAL LIABILITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEGLIGENCE; NONHUMAN; REVIEW; RISK FACTOR;

EID: 61449215969     PISSN: 12329142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Stefani S., Varaldo P. E.: Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect., 2003, 9, 1179-1186.
2. Melter O., Aires de Sousa M., Urbášková P., Jakubu V., Žemličková H., de Lencastre H.: Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic. J. Clin. Microbiol., 2003, 41, 4998-5005.
3. Sader H. S., Streit J. M., Fritsche T. R., Jones R. N.: Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2204). Clin. Microbiol. Infect., 2006, 12, 844-852.
4. Fluit A. C., Wielders C. L. C., Verhoef J., Schmitz F. J.: Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY Study. J. Clin. Microbiol., 2001, 39, 3727-3732.
5. Styers D., Sheehan D. J., Hogan P., Sahm D. F.: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob., 2006, 5, [http://www.ann-clinmicrob.com/ content/5/1/2].
6. CDC NNIS System: National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control, 2004, 32, 470-485.
7. Diekema D. J., Pfaller M. A., Schmitz F. J., Smayevsky J., Bell J., Jones R. N., Beach M. and the SENTRY Participants Group: Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis., 2001, 32 (supplement 2), S114-S132.
8. Bell J. M., Turnidge J. D. and SENTRY APAC Participants: High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob. Agents Chemother., 2002, 46, 879-881.
9. Pfaller M. A., Jones R. N., Doern G. V., Kugler K. and the SENTRY Participants Group: Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother., 1998, 42, 1762-1770.
10. Tacconelli E.: Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies. Clin. Microbiol. Infect., 2008, 14, 407-410.
11. Borg M. A.: Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings. J. Hosp. Infect., 2003, 54, 316-318.
12. Lee S. C., Chen K. S., Tsai C. J., Lee C. C., Chang H. Y., See L. C. Kao Y. C., Chen S. C., Wang C. H.: An outbreak of methicillin-resistant Staphylococcus aureus infections related to central venous catheters for hemodialysis. Infect. Control Hosp. Epidemiol., 2004, 25, 678-684.
13. Lodise T. P., McKinnon P. S., Rybak M.: Prediction model to identify patients with Staphylococcus aureus bacteraemia at risk for methicillin resistance. Infect. Control Hosp. Epidemiol., 2003, 24, 655-661.
14. Manian F. A., Meyer P. L., Setzer J., Senkel D.: Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role?. Clin. Infect. Dis., 2003, 36, 863-868.
15. Marshall C., Harrington G., Wolfe R., Fairley C. K., Wesselingh S., Spelman D.: Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect. Control Hosp. Epidemiol., 2003, 24, 322-326.
16. Marshall C., Wolfe R., Kossmann T., Wesselingh S., Harrington G.: Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J. Hosp. Infect., 2004, 57, 245-252.
17. Tacconelli E.: New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin. Microbiol. Infect., 2006, 12, 102-109.
18. Kluytmans J., van Belkum A., Verbrugh H.: Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev., 1997, 10, 505-520.
19. Cole A. M., Tahk S., Oren A., Yoshioka D., Kim Y. H., Park A., Ganz T.: Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol., 2001, 8, 1064-1069.
20. Vanden Bergh M. F. Q., Verbrugh H. A.: Carriage of Staphylococcus aureus: epidemiology and clinical relevance. J. Lab. Clin. Med., 1999, 133, 525-534.
21. Nicolle L. E.: Community-acquired methicillin-resistant Staphylococcus aureus: getting over it. Can. J. Infect. Dis. Med. Microbiol., 2005, 6, 323-324.
22. Smith A. J., Jackson M. S., Bagg J.: The ecology of Staphylococcus species in the oral cavity. J. Med. Microbiol., 2001, 50, 940-946.
23. Lu P. L., Chin L. C., Peng C. F., Chiang Y. H., Chen T. P., Ma L., Siu L. K.: Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J. Clin. Microbiol., 2005, 43, 132-139.
24. Nouwen J., Boelens H., van Belkum A., Verbrugh H.: Human factor in Staphylococcus aureus nasal carriage. Infect. Immun., 2004, 72, 6685-6688.
25. van Wamel W. J. B., Fluit A. C., Wadstrom T., van Dijk H., Verhoef J., Vandenbroucke-Grauls C. M. J. E.: Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol., 1995, 33, 1769-1774.
26. Berglund C., Mölling P., Sjöberg L., Söderquist B.: Predominance of staphylococcal cassette chromosome mec SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin. Microbiol. Infect., 2005, 11, 447-456.
27. Campbell K. M., Vaughn A. F., Russell K. L., Smith B., Jimenez D. L., Barrozo C. P., Minarcik J. R., Crum N. F., Ryan M. A. K.: Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J. Clin. Microbiol., 2004, 42, 4050-4053.
28. Hsu L. Y., Koh T. H., Tan T. Y., Ito T., Ma X. X., Lin R. T., Tan B. H.: Emergence of community-associated methicillin-resistant Staphylococcus aureus in Singapore: a further six cases. Singapore Med. J., 2006, 47, 20-26.
29. Okuma K., Iwakawa K., Turnidge J. D., Grubb W. B., Bell J. M., O'Brien F. G., Coombs G. W., Pearman J. W., Tenover F. C., Kapi M., Tiensasitorn C., Ito T., Hiramatsu K.: Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol., 2002, 40, 4289-4294.
30. Udo E. E., Al-Sweih N., Noronha B.: Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals. Clin. Microbiol. Infect., 2006, 12, 262-269.
31. Hidron A. I., Kourbatova E. V., Halvosa J. S., Terrell B. J., McDougal L. K., Tenover F. C., Blumberg H. M., King M. D.: Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin. Infect. Dis., 2005, 41, 159-166.
32. Rohr U., Wilhelm M., Muhr G., Gatermann S.: Qualitative and (semi)quantitative characterization of nasal and skin methicillin-resistant Staphylococcus aureus carriage of hospitalized patients. Int. J. Hyg. Environ. Health, 2004, 207, 51-55.
33. Chastre J.: Evolving problems with resistant pathogens. Clin. Microbiol. Infect., 2008, 14 (supplement 3), S3-S14.
34. Carmeli Y.: Strategies for managing today's infections. Clin. Microbiol. Infect., 2008, 14 (supplement 3), S22-S31.
35. Broda M.: Hospital strains of staphylococci - issues related to drug resistance (Szpitalne szczepy gronkowców - zagadnienia zwiazane z lekoopornościa). Kwart. Ortop., 2004, 1, 7-13 (in Polish).
36. Gardam M. A.: Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature. Can. J. Infect. Dis., 2000,4, 202-211.
37. Nicolle L.: Community-acquired MRSA: a practitioner's guide. CMAJ, 2006, 2, 145-146.
38. Cespedes C., Miller M., Quagliarello B., Vavagiakis P., Klein R. S., Lowy F.: Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J. Clin. Microbiol., 2002, 40, 2594-2597.
39. von Eiff C., Becker K., Machka K., Stammer H., Peters G.: Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med., 2001, 344, 11-16.
40. Alothman A., Jelani A., Althaqafi A., Rich M., Williams E.: Contamination of patient hospital charts by bacteria. J. Hosp. Infect., 2003, 55, 304-305.
41. Bebbington A., Parkin I., James P. A., Chichester L. J., Kubiak E. M.: Patients' case-notes: look but don't touch. J. Hosp. Infect., 2003, 55, 299-301.
42. Maluf M. E. Z., Maldonado A. F., Bercial M. E., Pedroso S. A.: Stethoscope: a friend or an enemy?. Sao Paulo Med. J./Rev. Paul. Med., 2002, 120, 13-15.
43. Knobloch J. K. M., Horstkotte M. A., Rohde H., Kaulfers P. M., Mack D.: Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J. Antimicrob. Chemother., 2002, 49, 683-687.
44. Russell A. D.: Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J. Hosp. Infect., 2004, 57, 97-104.
45. Lemmen S. W., Häfner H., Zolldann D., Stanzel S., Lütticken R.: Distribution of multi-resistant Gram-negative versus Gram-positive bacteria in the hospital inanimate environment. J. Hosp. Infect., 2004, 56, 191-197.
46. Neely A. N., Maley M. P.: Survival of enterococci and staphylococci on hospital fabrics and plastic. J. Clin. Microbiol., 2000, 38, 724-726.
47. Watson S. P., Clements M. O., Foster S. J.: Characterization of the starvation-survival response of Staphylococcus aureus. J. Bacteriol., 1998, 180, 1750-1758.
48. Vriens M. R., Fluit A. C., Troelstra A., Verhoef J., van der Werken C.: Is methicillin- resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit?. Infect. Control Hosp. Epidemiol., 2002, 23, 491-494.
49. Gopal Rao G., Wong J.: Interaction between methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA). J. Hosp. Infect., 2003, 55, 116-118.
50. Cartolano G. L., Cheron M., Benabid D., Leneveu M., Boisivon A., and the Association of Hospital Bacteriologists, Virologists and Hygiene Professionals: Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals. Clin. Microbiol. Infect., 2004, 10, 448-451.
51. Center K. J., Reboli A. C., Hubler R., Rodgers G. L., Long S. S.: Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J. Clin. Microbiol., 2003, 41, 4660-4665.
52. Kumhar G. D., Ramachandran V. G., Gupta P.: Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India. J. Health Popul. Nutr., 2002, 20, 343-347.
53. Mallaval F. O., Carricajo A., Delavenna F., Recule C., Fonsale N., Manquat G., Raffenot D., Rogeaux O., Aubert G., Tous J.: Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clin. Microbiol. Infect., 2004, 10, 459-461.
54. Abb J.: Frequency and diversity of molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients of a South West German teaching hospital. J. Hosp. Infect., 2004, 56, 232-235.
55. Horvat R. T., Klutman N. E., Lacy M. K., Grauer D., Wilson M.: Effect of duplicate isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus on antibiogram data. J. Clin. Microbiol., 2003, 41, 4611-4616.
56. Broda M., Ciebiada I., Denys A.: Clonal transmission of methicillin-resistant Staphylococcus aureus (MRSA) in two surgical wards of a hospital in Lodz (Klonalna transmisja metycylino-opornego szczepu S. aureus (MRSA) w dwóch oddziałach zabiegowych szpitala łódzkiego. Przegl. Epidemiol., 2008, 62, 19-27 (in Polish).
57. Higa N., Sithivong N., Phantouamath B., Insisiengmay S., Miyazato T., Iwanaga M.: Initial stage of hospital contamination with methicillin-resistant Staphylococcus aureus in Lao People's Democratic Republic. J. Hosp. Infect., 2004, 56, 125-130.
58. Montesinos I., Salido E., Delgado T., Cuervo M., Sierra A.: Epidemiologic genotyping of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms. J. Clin. Microbiol., 2002, 40, 2119-2125.
59. Krawczyk B.: Molecular biology techniques in epidemiological investigations of hospital infections (Techniki biologii molekularnej w badaniach epidemiologicznych zakażeń szpitalnych). Zakażenia, 2005, 4, 106-109 (in Polish).
60. Masny A., Płucienniczak A.: Ligation mediated PCR performer at low denaturation temperatures - PCR melting profiles. Nucleic Acids Res., 2003, 31, e114.
61. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B.: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 1995, 33, 2233-2239.
62. Enright M. C., Day N. P. J., Davies C. E., Peacock S. J., Spratt B. G.: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol., 2000, 38, 1008-1015.
63. French G. L., Otter J. A., Shannon K. P., Adams N. M. T., Watling D., Parks M. J.: Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J. Hosp. Infect., 2004, 57, 31-37.
64. Schultsz C., Meester H. H. M., Kranenburg A. M. H., Savelkoul P. H. M., Boeijen-Donkers L. E. A., Kaiser A. M., de Bree R., Snow G. B., Vandenbroucke-Grauls C. J. M. E.: Ultra-sonic nebulizers as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in a university tertiary care hospital. J. Hosp. Infect., 2003, 55, 269-275.
65. CDC: Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Morb. Mortal. Wkly Rep., 2002, 51, 1-45.
66. Girou E., Chai S. H. T., Oppein F., Legrand P., Ducellier D., Cizeau F., Brun-Buisson C.: Misuse of gloves: the foundation for poor compliance with hand hygiene and potential for microbial transmission?. J. Hosp. Infect., 2004, 57, 162-169.
67. Kampf G.: The six golden rules to improve compliance in hand hygiene. J. Hosp. Infect., 2004, 56, S3-S5.
68. McBryde E. S., Bradley L. C., Whitby M., McElwain D. L. S.: An investigation of contact transmission of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect., 2004, 58,104-108.
69. O'Malley A., Varadharajan V., Lok S.: Hand decontamination by medical staff in general medical wards. J. Hosp. Infect., 2005, 59, 369-370.
70. Rotter M. L.: European norms in hand hygiene. J. Hosp. Infect., 2004, 56, S6-S9.
71. Silvestri L., Petros A. J., Sarginson R. E., de la Cal M. A., Murray A. E., van Saene H. K. F.: Handwashing in the intensive care unit: a big measure with modest effects. J. Hosp. Infect., 2005, 59, 172-179.
72. Al-Damouk M., Pudney E., Bleetman A.: Hand hygiene and aseptic technique in the emergency department. J. Hosp. Infect., 2004, 56, 137-141.
73. Aksoy D. Y., Unal S.: New antimicrobial agents for the treatment of Gram-positive bacterial infections. Clin. Microbiol. Infect., 2008, 14, 411-420.
74. Moreillon P.: New and emerging treatment of Staphylococcus aureus infections in the hospital settings. Clin. Microbiol. Infect., 2008, 14 (supplement 3), S32-S41.
75. Graninger W.: Serious staphylococcal infections - cyclic lipopeptides: meeting new challenges. Clin. Microbiol. Infect., 2008, 14 (supplement 2), S1-S2.
76. Jones R. N.: Key considerations in the treatment of complicated staphylococcal infections. Clin. Microbiol. Infect., 2008, 14 (supplement 2), S3-S9.
77. Marchese A., Schito G. C.: The oxazolidinones as a new family of antimicrobial agents. Clin. Microbiol. Infect., 2001, 7 (supplement 4), S66-S74.
78. Muller-Serieys C., Drugean H. B., Etienne J., Lascols C., Leclercq R., Nguyen J., Soussy C. J.: Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in vitro susceptibility testing methods. Clin. Microbiol. Infect., 2004, 10, 242-246.
79. Werner G., Cuny C., Schmitz F. J., Witte W.: Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. J. Clin. Microbiol., 2001, 39, 3586-3590.
80. Ackermann G., Rodloff A. C.: Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide. J. Antimicrob. Chemother., 2003, 51, 497-511.
81. Eisenstein B. I.: Treatment of staphylococcal infections with cyclic lipopeptides. Clin. Microbiol. Infect., 2008, 14 (supplement 2), S10-S16.
82. Eisenstein B. I.: Treatment challenges in the management of complicated skin and soft-tissue infections. Clin. Microbiol. Infect., 2008, 14 (supplement 2), S17-S25.
83. Rybak M. J.: The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Clin. Microbiol. Infect., 2006, 12 (supplement 1), S24-S32.
84. Vikram H. R., Havill N. L., Koeth L. M., Boyce J. M.: Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin. J. Clin. Microbiol., 2005, 43, 5384-5387.
85. Dalkowska A., Gaworska-Krzemińska A., Krzemiński M.: Roszczenia pacjenta - konsekwencje cywilnoprawne ran powikłanych. Zakażenia, 2007, 3, 80-84.
86. Engemann J. J., Carmeli Y., Cosgrove S. E., Fowler V. G., Bronstein M. Z., Trivette S. L., Briggs J. P., Sexton D. J., Kaye K. S.: Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis., 2003, 36, 592-598.
87. Nichols R. L., Florman S.: Clinical presentations of soft-tissue infections and surgical site infections. Clin. Infect. Dis., 2001, 33 (supplement 2), S84-S93.
88. Smith R. L., Bohl J. K., McElearney S. T., Friel C. M., Barclay M. M., Sawyer R. G., Foley E. F.: Wound infection after elective colorectal resection. Ann. Surg., 2004, 239, 599-607.
89. Świechowski M., Gajdosz R.: Hospital pulmonary infections in patients from an intensive care unit (Szpitalne zapalenia płuc u pacjentów na oddziale intensywnej terapii). Zakażenia, 2001, 3, 10-13 (in Polish).
90. Wojciechowski A.: The incessarily lost billions of zlotys (Niepotrzebnie tracone miliardy. Zakażenia, 2002, 1-2, 58-61 (in Polish).
91. Raza M. W., Kazi B. M., Mustafa M., Gould F. K.: Developing countries have their own characteristic problems with infection control. J. Hosp. Infect., 2004, 57, 294-299.
92. Charkowska A.: Norms of the cleanliness of air and hospital surfaces (Normy czystości powietrza i powierzchni szpitalnych. Zakażenia, 2006, 6, 76-78 (in Polish).
93. Gebel J., Exner M.: Routine disinfection of surfaces as an element of the hospital hygiene in Germany (Rutynowa dezynfekcja powierzchni jako element higieny szpitalnej w Niemczech). Zakażenia, 2006, 6, 16-20 (in Polish).
94. Leroyer A., Bedu A., Lombrail P., Desplanques L., Diakite B., Bingen E., Aujard Y., Brodin M.: Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit. J. Hosp. Infect., 1997, 35, 37-45.
95. Senna J. P. M., Pinto C. A., Bernardon D. R., Francisco A. G., Epztein E., Ritt C. B., Oppermann C., Santos D. S.: Identification of methicillin-resistant Staphylococcus aureus among care-workers and patients in an emergency hospital. J. Hosp. Infect., 2003, 54, 167-168.
96. Schelenz S., Tucker D., Georgeu C., Daly S., Hill M., Roxburgh J., French G. L.: Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J. Hosp. Infect., 2005, 60, 104-110.
97. Wernitz M. H., Keck S., Swidsinski S., Schulz S., Veit S. K.: Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin. Microbiol. Infect., 2005, 11, 466-471.
98. Wernitz M. H., Swidsinski S., Weist K., Sohr D., Witte W., Franke K. P., Roloff D., Rüden H., Veit S. K.: Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin. Microbiol. Infect., 2005, 11, 457-465.
99. Bolyard E. A., Tablan O. C., Williams W. W., Pearson M. L., Shapiro C. N., Deitchman S. C. and the Hospital Infection Control Practices Advisory Committee: Guideline for infection control in health care personnel, 1998. Am. J. Infect. Control, 1998, 26, 289-354.
100. Cooper B. S., Stone S. P., Kibbler C. C., Cookson B. D., Roberts J. A., Medley G. F., Duckworth G., Lai R., Ebrahim S.: Isolation measures in the hospital management of methicillin-resistant Staphylococcus aureus (MRSA): systemic review of the literature. BMJ, 2004, 329, 533-538.
101. Muto C. A., Jernigan J. A., Ostrowsky B. E., Richet H. M., Jarvis W. R., Boyce J. M., Farr B. M.: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol., 2003, 24, 362-386.
102. van Saene H. K. F., Weir W. I., de la Cal M. A., Silvestri L., Petros A. J., Barrett S. P.: MRSA - time for a more pragmatic approach?. J. Hosp. Infect., 2004, 56, 170-174.